Chelsea Counsel CO Prime Medicine, Inc. Transaction History

Chelsea Counsel CO

  • $191 Million
  • Q4 2024

A detailed history of Chelsea Counsel CO transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Chelsea Counsel CO holds 186,780 shares of PRME stock, worth $371,692. This represents 0.28% of its overall portfolio holdings.

Number of Shares
186,780
Previous 78,690 137.36%
Holding current value
$371,692
Previous $304,000 79.28%
% of portfolio
0.28%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 27, 2025
BUY
$2.64 - $4.46 $285,357 - $482,081
108,090 Added 137.36%
186,780 $545,000
Q3 2024

Nov 21, 2024
BUY
$3.41 - $6.7 $3,410 - $6,700
1,000 Added 1.29%
78,690 $304,000
Q2 2024

Nov 21, 2024
BUY
$4.3 - $8.03 $312,567 - $583,700
72,690 Added 1453.8%
77,690 $399,000
Q4 2023

Feb 21, 2024
BUY
$5.59 - $9.55 $24,596 - $42,020
4,400 Added 733.33%
5,000 $44,000
Q4 2022

Feb 23, 2023
BUY
$15.2 - $21.12 $9,120 - $12,672
600 New
600 $11,000

Others Institutions Holding PRME

# of Institutions
137
Shares Held
61.1M
Call Options Held
42.6K
Put Options Held
173K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $191M
More about PRME
Track This Portfolio

Track Chelsea Counsel CO Portfolio

Follow Chelsea Counsel CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

News

Stay updated on Chelsea Counsel CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email